Accuray Incorporated (ARAY): Price and Financial Metrics
Accuray Incorporated (ARAY)
Today's Latest Price: $4.40 USD
Updated Nov 23 6:55pm
Add ARAY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
ARAY Stock Summary
- Accuray Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 93.26% of US listed stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 7.8 for Accuray Inc; that's greater than it is for 86.11% of US stocks.
- Over the past twelve months, ARAY has reported earnings growth of -205.3%, putting it ahead of just 9.56% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Accuray Inc are CSGS, TDC, CYRN, THRM, and RAVN.
- ARAY's SEC filings can be seen here. And to visit Accuray Inc's official web site, go to www.accuray.com.
ARAY Stock Price Chart Interactive Chart >
ARAY Price/Volume Stats
| Current price | $4.40 | 52-week high | $4.68 |
| Prev. close | $3.91 | 52-week low | $1.33 |
| Day low | $3.91 | Volume | 3,497,800 |
| Day high | $4.62 | Avg. volume | 699,265 |
| 50-day MA | $3.00 | Dividend yield | N/A |
| 200-day MA | $2.45 | Market Cap | 401.61M |
Accuray Incorporated (ARAY) Company Bio
Accuray Inc. designs, develops, and sells radio-surgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radio-surgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The company was founded in 1990 and is based in Sunnyvale, California.
Loading social stream, please wait...